Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-13,582
Closed -$787K 378
2017
Q2
$787K Sell
13,582
-23
-0.2% -$1.34K 0.01% 305
2017
Q1
$796K Sell
13,605
-10,738
-44% -$609K 0.01% 315
2016
Q4
$1.35M Sell
24,343
-2,626
-10% -$140K 0.01% 431
2016
Q3
$1.27M Sell
26,969
-15,622
-37% -$743K 0.01% 432
2016
Q2
$1.84M Sell
42,591
-1,552
-4% -$64K 0.01% 339
2016
Q1
$1.51M Sell
44,143
-5,329
-11% -$210K 0.01% 400
2015
Q4
$3.93M Sell
49,472
-4,566
-8% -$320K 0.03% 223
2015
Q3
$3.17M Sell
54,038
-52,915
-49% -$3.49M 0.02% 256
2015
Q2
$6.88M Buy
106,953
+15,967
+18% +$977K 0.04% 201
2015
Q1
$5.55M Buy
+90,986
New +$6.22M 0.03% 370

Other funds holding ALKS

TCW Group's ALKS Position: Q3 2017 in Review

TCW Group sold out of Alkermes (ALKS) in Q3 2017, closing a stake of 13,582 shares — an estimated $787K sold.

TCW Group first reported a position in ALKS in Q1 2015 and held it in 10 quarters. The position peaked at $6.88M in Q2 2015. 244 funds tracked by Wall St. Rank hold ALKS as of Q3 2017.

  • TCW Group reported no remaining Alkermes position as of Q3 2017 after selling out during the quarter.
  • TCW Group sold 13,582 Alkermes shares in Q3 2017, an estimated $787K.
  • TCW Group first reported a position in Alkermes in Q1 2015 and held it in 10 quarters.
  • TCW Group's Alkermes position peaked at $6.88M in Q2 2015.
  • 244 funds tracked by Wall St. Rank held Alkermes as of Q3 2017.

Based on TCW Group's 13F filing for Q3 2017, filed 6 Nov 2017.